GlaxoSmithKline

Paper Summary:

This paper provides a business case analysis of GlaxoSmithKline, a renowned pharmaceutical company. It describes the company's current performance and their business objectives. The paper also provides a SWOT (strengths, weaknesses, opportunities, threats) analysis for the internal environment and the external environment of the company. Finally, the paper looks at strategic alternatives and provides recommendations for the future of the company. The paper is largely in point form.

Table of Contents:
Current Situation
Current Performance
Strategic Posture
Mission
Objectives
Strategies
Policies
Corporate Governance
Board of Directors
Top Management
External Environment: Opportunities and Threats (SWOT)
Societal Environment
Task Environment
Summary of External Factors
Internal Environment: Strengths and Weaknesses (SWOT)
Corporate Structure
Corporate Culture
Corporate Resources
Marketing
Finance
Research and Development (R&D)
Operations and Logistics
Human Resource Management
Information Systems (IS)
Summary of Internal Factors
Analysis of Strategic Factors (SWOT)
Situational Analysis
Review of Mission and Objectives
Strategic Alternatives and Recommended Strategy
Strategic Alternatives
Push Strategy
Reduce Production Costs
No Change Strategy
Recommended Strategy
Reduce Production Costs
Implementation
Evaluation and Control

From the Paper:

"In order to solve the problem posed by abroad purchases, GlaxoSmithKline has to reevaluate their pricing strategies within the United States. They explained that the discrepancy between prices in Canada and the prices in U.S. is due to different living standards and the two country's different GDPs. However, they have to understand that their primary consumers, that are the senior citizens, cannot afford the high prices on the U.S. market. In a first stage, the strategy might generate additional costs, but on the long run, it is the best strategy."

Sample of Sources Used:

• 2007, GlaxoSmithKline PLC GSK Ratios, Reuters Information on Stocks, http://stocks.us.reuters.com/stocks/ratios.asp?rpc=66&symbol=GSK, last accessed on October 26, 2007
• GlaxoSmithKline Official Website, http://gsk.com/, last accessed on October 28, 2007
• GlaxoSmithKline Annual Report for 2006, A Human Race, Retrieved on October 28, 2007 from http://www.gsk.com/investors/reps06/annual-report-2006.pdf
• Smith Shull, S., Morris, R.J., 2003, GlaxoSmithKline's Retaliation Against Cross-Border Sales of Prescription Drugs
• Boseley, S., February 18, 2003, Jean Pierre Garnier, Head of Glaxo, The Guardian, http://www.guardian.co.uk/aids/story/0,,897344,00.html, last accessed on October 26, 2007

More papers on GlaxoSmithKline:

• Case Study # 148880 : "GlaxoSmithKline's Weight Loss Program"
• Analytical Essay # 132948 : "GlaxoSmithKline"
• Business Plan # 108025 : "Marketing Strategy of GlaxoSmithKline (GSK)"

APA Citation:

MLA Citation: